psoriasis

Armstrong AW, Foley P, Liu Y, Miller M, Teneralli RE, Bewley A, Gordon KB, Papp KA, Han C. Direct and Indirect Effect of Guselkumab on[...]

James WA, Rosenberg AL, Wu JJ, Hsu S, Armstrong A, Wallace EB, Lee LW, Merola J, Schwartzman S, Gladman D, Liu C, Koo J, Hawkes[...]

Guo L, Bilimoria SN, Kikuchi R, Hao A, Tolson H, Yamamoto RK, Sadrolashrafi K, Yee D, Armstrong AW. Prevalence, Incidence, and Risk of Chronic Obstructive[...]

Korman NJ, Warren RB, Bagel J, Armstrong AW, Gooderham M, Strober B, Thaçi D, Morita A, Imafuku S, Foley P, Sofen H, Zheng M, Hippeli[...]

Armstrong AW, Park SH, Patel V, Nicolas P, Wang WJ, Colombo MJ, Chirikov V. Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to[...]

Gebauer K, Spelman L, Yamauchi PS, Bagel J, Nishandar T, Crane M, Kopeloff I, Kothekar M, Yao SL, Sofen HL. Efficacy and safety of tildrakizumab[...]

Elman SA, Perez-Chada LM, Armstrong A, Gottlieb AB, Merola JF. Psoriatic Arthritis: A Comprehensive Review for the Dermatologist.Part II: Screening and Management. J Am Acad[...]

Perez-Chada LM, Elman S, Villa-Ruiz C, Armstrong AW, Gottlieb AB, Merola JF. Psoriatic Arthritis: A comprehensive review for the dermatologist Part I: Epidemiology, Comorbidities, Pathogenesis,[...]

Armstrong AW, Jaleel T, Merola JF, Gottlieb AB, Khattri S, Helt CC, Malatestinic WN, Ross SE, Ngantcha ME, de Vlam K. Ixekizumab Demonstrates Rapid and[...]

Lebwohl MG, Koo JY, Armstrong AW, Strober BE, Martin GM, Rawnsley NN, Goehring EL Jr, Jacobson AA. Brodalumab: 5-Year US Pharmacovigilance Report. Dermatol Ther (Heidelb).[...]